Last reviewed · How we verify

Any FDA approved antipsychotic agent

Vanguard Research Group · FDA-approved active Small molecule

Any FDA approved antipsychotic agent is a Antipsychotic (dopamine antagonist) Small molecule drug developed by Vanguard Research Group. It is currently FDA-approved for Schizophrenia, Bipolar disorder (acute mania and maintenance), Psychotic disorders.

FDA-approved antipsychotics block dopamine and/or serotonin receptors in the brain to reduce psychotic symptoms and stabilize mood.

FDA-approved antipsychotics block dopamine and/or serotonin receptors in the brain to reduce psychotic symptoms and stabilize mood. Used for Schizophrenia, Bipolar disorder (acute mania and maintenance), Psychotic disorders.

At a glance

Generic nameAny FDA approved antipsychotic agent
SponsorVanguard Research Group
Drug classAntipsychotic (dopamine antagonist)
TargetDopamine D2 receptor (primary); serotonin 5-HT2A receptor and others (varies by agent)
ModalitySmall molecule
Therapeutic areaPsychiatry / Neurology
PhaseFDA-approved

Mechanism of action

Antipsychotics work primarily by antagonizing dopamine D2 receptors, which reduces excessive dopaminergic signaling implicated in psychosis. Many also block serotonin 5-HT2A receptors and other targets, contributing to efficacy across psychotic and mood disorders. The specific receptor profile varies by agent (typical vs. atypical antipsychotics).

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Any FDA approved antipsychotic agent

What is Any FDA approved antipsychotic agent?

Any FDA approved antipsychotic agent is a Antipsychotic (dopamine antagonist) drug developed by Vanguard Research Group, indicated for Schizophrenia, Bipolar disorder (acute mania and maintenance), Psychotic disorders.

How does Any FDA approved antipsychotic agent work?

FDA-approved antipsychotics block dopamine and/or serotonin receptors in the brain to reduce psychotic symptoms and stabilize mood.

What is Any FDA approved antipsychotic agent used for?

Any FDA approved antipsychotic agent is indicated for Schizophrenia, Bipolar disorder (acute mania and maintenance), Psychotic disorders, Agitation associated with dementia or delirium.

Who makes Any FDA approved antipsychotic agent?

Any FDA approved antipsychotic agent is developed and marketed by Vanguard Research Group (see full Vanguard Research Group pipeline at /company/vanguard-research-group).

What drug class is Any FDA approved antipsychotic agent in?

Any FDA approved antipsychotic agent belongs to the Antipsychotic (dopamine antagonist) class. See all Antipsychotic (dopamine antagonist) drugs at /class/antipsychotic-dopamine-antagonist.

What development phase is Any FDA approved antipsychotic agent in?

Any FDA approved antipsychotic agent is FDA-approved (marketed).

What are the side effects of Any FDA approved antipsychotic agent?

Common side effects of Any FDA approved antipsychotic agent include Extrapyramidal symptoms (tremor, rigidity, akathisia), Weight gain, Metabolic syndrome (hyperglycemia, dyslipidemia), Prolactin elevation (galactorrhea, sexual dysfunction), Sedation, Orthostatic hypotension.

What does Any FDA approved antipsychotic agent target?

Any FDA approved antipsychotic agent targets Dopamine D2 receptor (primary); serotonin 5-HT2A receptor and others (varies by agent) and is a Antipsychotic (dopamine antagonist).

Related